Hepatitis C on the rise among reproductive-aged women
1. The number of reproductive-aged women infected with HCV doubled from 2006 to 2014. 2. HCV infection among children was ...
Tag: hepatitis C
Direct-acting antiviral therapy for hepatitis C virus associated with hepatitis B virus reactivation in co-infected patients
1. Patients who have been infected with hepatitis B virus (HBV) and are being treated with direct-acting antiviral agents (DAAs) ...
Multiple oral direct-acting antiviral regimens associated with sustained virologic response for hepatitis C virus infection
1. Multiple oral direct-acting antiviral (DAA) interferon-free therapies with high SVR rates are available for all six hepatitis C virus ...
Ledipasvir-sofosbuvir may be safe treatment for kidney transplant recipients with chronic HCV
1. Ledipasvir-sofosbuvir treatment was associated with rapid chronic hepatitis C (HCV) RNA suppression. 2. Ledipasvir-sofosbuvir treatment was generally well tolerated ...
HBV and HCV coinfection may increase non-Hodgkin’s lymphoma risk in HIV-infected patients
1. Compared to the HIV-negative population, chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection was found to ...
Hepatitis C screening in prisons may reduce transmission and infection rates
1. According to a model simulation, implementation of an opt-out prison screening protocol would diagnose at least 81,000 hepatitis C ...
![[CORAL-1 trial] Interferon-free regimen for recurrent hepatitis C after liver transplant safe and effective](https://www.2minutemedicine.com/wp-content/uploads/2014/11/10229_lores-350x250.jpg)
Sofosbuvir-velpatasvir may provide sustained virologic response in Hepatitis C cirrhotics: The ASTRAL-4 study
1. Sofosbuvir-velpatasvir with or without ribavirin resulted in sustained virologic response at 12 weeks across all hepatitis C virus ...
Sofosbuvir-velpatasvir shows promise in HCV genotype 2 and 3 infection: The ASTRAL 2-3 study
1. Among patients with hepatitis C virus (HCV) genotype 2 or 3, 12 weeks of treatment with a once-daily, fixed-dose, ...
National acute HCV infections may be underestimated
1. Less than 1% of clinically diagnosed acute cases of hepatitis C virus (HCV) infection in Massachusetts were reported to ...
![Novel combination therapy may be effective for noncirrhotic HCV infection [UNITY-1 trial]](https://www.2minutemedicine.com/wp-content/uploads/2015/05/cirrhosis2-350x250.jpg)
Novel combination therapy may be effective for noncirrhotic HCV infection [UNITY-1 trial]
1. Amongst patients who were infected with hepatitis C genotype 1 and who did not have cirrhosis, receiving treatment with ...